Skip to main content
Signal8

Adamchak Mark

SEC insider (Form 3/4/5 filer). CIK 0002036536. Principal Accounting Officer at Bionano Genomics, Inc. (BNGO). 8 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in SAN DIEGO, CA.

Companies Adamchak Mark has filed insider reports for

  • Bionano Genomics, Inc. (BNGO): Officer, Principal Accounting Officer
Adamchak Mark profile photo

Adamchak Mark

CIK: 0002036536

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Bionano Genomics, Inc. logo
BNGO

Bionano Genomics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Aug 3, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    5K shares-
  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Jun 3, 2026
    Tax Payment
    Direct
    7 shares at avg. $1.30$9.1
  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Feb 17, 2026
    Tax Payment
    Direct
    3 shares at avg. $1.10$3.3
  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Feb 2, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    10.9K shares-
  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Jun 3, 2025
    Tax Payment
    Direct
    7 shares at avg. $3.69$25.83
  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Mar 14, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    3K shares-
  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Feb 15, 2025
    Tax Payment
    Direct
    4 shares at avg. $5.73$22.92
  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Oct 1, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    17.5K shares-

1-8 of 8